Chinidin

Quick links to important sections

Chinidin

Method of action: Antiarrhythmic, Group Ia

Treatment option: Tachycardia, AF

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Chinidin

Quick Facts: Chinidin

Property Description
Active ingredient Quinidine (as sulfate or gluconate)
Form Oral tablets, Solution for injection
Pharmacological class Class Ia Antiarrhythmic Agent
General purpose Normalizes and maintains heart rhythm
Origin Natural product (Cinchona tree bark)

What Type of Medicine is Chinidin?

Chinidin is a highly specialized medicine whose active component is Quinidine, a potent alkaloid with a significant history in therapeutics. It is classified as an antiarrhythmic agent (Antidysrhythmic), used specifically for its electrical stabilizing properties within the heart. Quinidine's action as a Class Ia antiarrhythmic agent is defined by its pharmacological properties, establishing its primary role in managing abnormal cardiac rhythms. This classification highlights its unique mechanism of action as a Na^+ (sodium ion) channel modulator, which is key to its effect on the heart's electrical recovery period.


Origin, Composition, and Forms

The defining feature of Chinidin is the origin of its active substance: Quinidine is a natural product extracted from the bark of the Cinchona tree. This botanical derivation underscores its history, as this group of Cinchona alkaloids is historically known for multiple therapeutic applications. For current clinical use, the medicine is prepared as a single-ingredient product, primarily in two salt forms, Quinidine sulfate and Quinidine gluconate, which determine its release characteristics and administration route. The medicine is formulated as oral tablets (available in immediate-release and extended-release formats) and as a sterile solution for injection, offering versatility in its use.


General Purpose and Core Differentiation

The primary general purpose of Chinidin is to normalize and help maintain a steady, regular heart rhythm; this makes it crucial in situations where the heart is exhibiting electrical instability. Unlike some other rhythm medications that mainly slow the overall heart rate, Quinidine's mechanism specifically addresses the electrical discipline of the cardiac action potential, directly reducing the cell's excitability. Its unique dual therapeutic identity is a differentiating factor, as it also possesses utility as an antimalarial agent, confirming the substance's breadth of pharmacological activity.

What side effects are possible with Chinidin?

Chinidin: Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics of Chinidin (Quinidine), based on governmental regulatory sources like the FDA and EMA prescribing information. The safety profile is structured by frequency and the body system affected.


Adverse Reaction Scope

The most frequently classified adverse events are Gastrointestinal disturbances, including diarrhea, nausea, and vomiting, which are often cited as common or very common. Another frequently documented adverse reaction is Cinchonism, a syndrome encompassing symptoms like tinnitus, hearing loss, blurred vision, and headache, reflecting effects on the nervous and sensory systems.

Serious Adverse Reactions and Safety Constraints

The label specifies the risk of Serious Adverse Reactions, primarily involving the cardiovascular system. These include Proarrhythmia—the induction or worsening of heart rhythm disorders—most critically Torsades de Pointes, which is classified as a rare but life-threatening event. This risk is officially noted to be highest during the initial phase of therapy or following dose increases.

Severe Hematologic effects, such as Thrombocytopenia (low platelet count), and serious Hypersensitivity reactions are also documented.

Regulatory safety constraints mandate specific conditions for use. Patients with hypokalemia (low potassium) or hypomagnesemia must have these electrolyte imbalances corrected prior to treatment initiation, as they amplify the risk of serious proarrhythmia. Furthermore, caution and monitoring are required for patients with Renal or Hepatic Impairment due to potential drug accumulation.


Regulatory Safety Summary: The official safety profile is defined by the high incidence of gastrointestinal side effects and the critical need for intensive cardiac surveillance, including mandatory ECG monitoring (specifically for QT interval changes), to manage the documented risk of serious arrhythmias.

Overdose and Emergency Response

Overdose: When to Seek Help

Overdose involving Chinidin (Quinidine) is a medical emergency that requires immediate professional attention. Due to the high risk, any instance of overdose must be taken seriously, and action should be taken even if symptoms have not yet appeared.

Recognising Overdose Symptoms

Symptoms of a severe overdose can affect multiple physiological systems and may include:

  • Cardiovascular: Irregular or fast heartbeat, and dangerously low blood pressure.
  • Central Nervous System (CNS): Headache, confusion, convulsions, and progressing to coma.
  • Other Manifestations: Blurred vision, vomiting, abdominal pain, and breathing difficulties.

High-Risk Exposure

Chinidin overdose is considered potentially lethal. Regulatory information indicates that acute ingestion of 1 gram or more in adults, or any ingestion in children, should be treated as a potentially fatal event requiring urgent intervention.

Immediate Actions Required

If you suspect an overdose:

  1. Contact a healthcare practitioner, hospital emergency department, or regional Poison Control Centre immediately, regardless of symptoms.
  2. Call emergency services (such as 911) immediately if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Do not wait for symptoms to worsen. Follow the procedural instructions given by the emergency operators or poison control staff.

Therapeutic Uses of Chinidin

What Chinidin Treats: Main Uses and Benefits

Chinidin is a medication applied across domains where additional symptomatic support is needed and where symptoms related to heightened physiological activity or systemic imbalance are significant. This medicine is commonly used across conditions presenting with acute episodes where symptoms may intensify temporarily.

This includes conditions involving episodic or fluctuating manifestations such as Atrial Fibrillation, Atrial Flutter, and certain Ventricular Arrhythmias, as well as conditions associated with acute or disruptive episodes like severe Plasmodium falciparum malaria and Pseudobulbar Affect. For heart rhythm disorders, Chinidin may assist with managing symptoms like frequent palpitations and irregular heart rate.

“Chinidin supports efforts to maintain a sense of stability during periods of symptom fluctuation,” providing symptomatic relief that helps patients cope more steadily. In the context of severe infection, it plays a role in managing the heightened systemic burden, and in neurological contexts, it assists with maintaining functional stability when symptoms interfere with daily comfort.


Quick Fact: Supportive Management for Symptoms Related to Heightened Physiological Activity

Property Description
Primary Focus Symptoms linked to organ-specific functional stress
Symptom Goal Helps address palpitations and irregular heart rate
Therapeutic Benefit Contributes to easing the overall symptom load
Contextual Use Applied for recurrent and episodic manifestations

Regulatory References

  1. FDA DailyMed Drug Label for Quinidine Sulfate

Eligibility and Restrictions for Use

Who can and cannot use Chinidin?

Chinidin (Quinidine) eligibility is strictly defined by regulatory documents, with numerous absolute prohibitions and conditional use requirements.

Contraindicated Populations and Conditions

Classification Population/Condition
Absolute Contraindication Patients with a prolonged QT interval or history of Torsades de Pointes.
Absolute Contraindication Complete Atrioventricular (AV) block without an implanted pacemaker.
Absolute Contraindication Known hypersensitivity to quinidine, quinine, or mefloquine.
Absolute Contraindication Myasthenia Gravis, G6PD deficiency, or Optic Neuritis.

Age and Organ Function Restrictions

Classification Population/Condition
Conditional Use Severe Hepatic (Liver) Impairment (use is not recommended in severe cases).
Conditional Use Severe Renal (Kidney) Impairment (caution is advised, may require monitoring).
Age-Related Rule Pediatric antiarrhythmic use is officially not established; use in older adults may require caution due to slower drug removal.
Reproductive Status Pregnancy Category C; drug is excreted into human milk, and discontinuation of the drug or nursing is advised.

These official statements collectively determine who is eligible for use, with specific cardiac and systemic health markers defining absolute non-eligibility, and organ function dictating conditional use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction scope

Category Official Regulatory Statements
Medicinal product categories with documented interactions Antiarrhythmic Agents, Neuromuscular Blocking Agents, Urine Alkalinizers, Strong CYP3A4 Modulators, CYP2D6 Substrates, Drugs that Prolong the QTc Interval.
Specific interacting medicines (if explicitly listed) Dofetilide, Digoxin, Amiodarone, Verapamil, Diltiazem, Cimetidine, Metoprolol, Thiazide Diuretics.
Mechanistic basis of interactions (only if stated in label) Potent inhibition of Cytochrome P450 2D6 (CYP2D6), Inhibition of P-glycoprotein (P-gp), Substrate of CYP3A4, Reduced renal elimination due to urine alkalinization, Additive cardiac effects (QTc prolongation).
Population-specific interaction notes (if applicable) Liver dysfunction (Hepatic impairment) and Kidney dysfunction (Renal impairment) are documented to slow elimination, resulting in higher plasma levels and potential increased risk of adverse effects.

Resulting interaction structure

Co-administration with Dofetilide and other QTc-prolonging medicines is formally contraindicated due to the risk of additive cardiac effects. Chinidin's potent inhibition of CYP2D6 and P-glycoprotein (P-gp) is documented to increase the plasma exposure of many co-administered drugs, including Digoxin, whose serum levels may be doubled. Substances that alkalinize the urine, such as Thiazide Diuretics, are documented to reduce the renal elimination of Chinidin, which can increase its concentration. Additionally, Grapefruit juice is documented to affect Chinidin's metabolism and should be avoided.

Mechanism of Action

Modulating Cardiac Electrical Channels

Chinidin acts by blocking the fast inward movement of sodium ( Na^+) and key outward currents of potassium ( K^+) ions across the cardiac cell membrane. This block alters the electrical potential, slowing the speed of signal conduction and prolonging the effective refractory period (ERP).


⏳ Prolonging the Cell Reset Time

By inhibiting K^+ currents, the drug extends the effective refractory period (ERP) of the cardiac tissue. This extension of the cell's recovery time creates an environment that disrupts the necessary electrical conditions for re-entry circuits to continue.


Affecting Autonomic Control and Blood Flow

The drug also engages secondary mechanisms by interfering with muscarinic acetylcholine receptors and alpha-1 adrenergic receptors. This activity reduces the inhibitory tone of the Vagus nerve on the heart and promotes the relaxation of smooth muscle in the blood vessels, resulting in peripheral vasodilation.

Dosage and Administration Information

Chinidin (quinidine) is a Class Ia antiarrhythmic agent and antimalarial medication. It must be taken exactly as prescribed by your healthcare provider. Dosing is highly individualized based on the condition being treated, the formulation (immediate-release or extended-release), and individual patient response, and often requires careful monitoring in a hospital setting when therapy is initiated or the dose is adjusted.

  • Oral Administration: Chinidin tablets can be taken with food to help reduce stomach upset. Swallow extended-release tablets (e.g., gluconate salt) whole; do not crush, chew, or break them, as this can release the entire dose at once and increase the risk of serious side effects. Some extended-release tablets may be passed whole in the stool, which is the empty shell remaining after the medication has been absorbed and is generally harmless.
  • Missed Dose: If you miss a dose, take it as soon as you remember. If it is close to the time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not double your dose to catch up, as this can lead to toxicity.
  • Monitoring: Your doctor will likely conduct regular tests, including electrocardiograms (EKG/ECG) and blood tests to measure chinidin levels and monitor your heart and organ function while you are on this medication. These tests are critical to ensure the drug is working safely and effectively. Do not stop taking the medication without speaking to your doctor first.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Chinidin

The available information on Chinidin (Quinidine) comes from different types of research, including Randomized Controlled Trials (RCTs), where people are randomly assigned to groups, and systematic reviews that combine the results of many studies. The purpose of this overview is to describe what the research has explored and what findings have been reported so far, using language that avoids making any clinical recommendations.


Research Evidence for Heart Rhythm Disorders (Atrial Fibrillation and Flutter)

Research has explored Chinidin's use in conditions characterized by fluctuating or episodic manifestations, including Atrial Fibrillation and Atrial Flutter. Studies examined patterns related to the rate of conversion to a more regular rhythm and whether that rhythm could be maintained over a defined time interval. The study designs primarily consisted of earlier RCTs and meta-analyses that synthesized the data from those trials.

Research reports patterns observed in the studies related to both the conversion rate and the stability of the rhythm. Systematic reviews described risk patterns related to mortality that were reported in the groups examined. The use of Chinidin in long-term rhythm management is not fully established by contemporary research standards, and research remains limited due to the specific risk patterns identified in systematic reviews of earlier trials.


Research Evidence in the Context of Severe Infectious Disease

Chinidin was evaluated in clinical trials and observational studies for its role in treating severe Plasmodium falciparum malaria. Research examined temporary physiological imbalance. The studies primarily focused on outcomes related to systemic or functional imbalance, such as measurements of the malaria parasite count in the blood, and the assessment of clinical markers such as fever clearance.

Findings describe patterns observed in the studies related to changes in parasite count. The evidence contributes to understanding symptom patterns and supports the substance's inclusion in therapeutic literature regarding this severe infection. Research is ongoing regarding the evolving landscape of antimalarial resistance across different global regions.

Key Studies & References Quinidine Sulfate Tablet (Quinidine Sulfate) FDA DailyMed Drug Label

Frequently Asked Questions (FAQ)

Common questions about Chinidin (FAQ)


Q: What main health conditions is Chinidin officially approved to treat?

Official regulatory information states that Chinidin (quinidine) is approved to treat specific abnormal heart rhythms. The medicine also has an approved indication for use in treating malaria.

Q: Is Chinidin the same thing as Quinine, and if not, what is the difference?

No, official sources indicate that quinidine and quinine are related but chemically distinct compounds. Quinidine is primarily used as an antiarrhythmic agent for the heart, while quinine is used primarily as an antimalarial agent.

Q: Why is Chinidin sometimes prescribed along with the drug Dextromethorphan?

Official regulatory approval exists for a combination product that includes quinidine and dextromethorphan to address a neurological condition known as pseudobulbar affect (PBA). This condition is characterized by episodes of inappropriate or involuntary crying or laughing.

Q: Is it possible for Chinidin to cause joint or muscle pain?

Regulatory documents note that rare side effects can include musculoskeletal issues such as joint pain, joint swelling, or muscle pain. If these effects occur, they are documented in the official safety profile.

Q: Can taking Chinidin make me more sensitive to the sun?

Official safety information indicates that increased sensitivity to light (photosensitivity) is a documented rare side effect. This condition can manifest as a rash that worsens when exposed to sunlight.

Q: Is there a risk of Chinidin worsening heart conditions like heart failure?

Official regulatory documents state that the medicine is contraindicated for use in patients who have certain types of heart failure. The eligibility requirements are strictly defined in the regulatory label.

Q: Is Chinidin used for a genetic condition called Brugada Syndrome?

Medical literature has examined the use of quinidine in selected patients who have Brugada Syndrome. This is a specialized area of use that is not included in the primary FDA approval indications.

Q: Has Chinidin been studied for safety and efficacy in treating Short QT Syndrome?

Research has examined quinidine for use in Short QT Syndrome. Official literature indicates that the substance may be used to prolong the heart’s QT interval, which is the desired physiological effect for this condition.

Q: Why are some people hesitant to use Chinidin compared to other treatments?

Official research reports have described risk patterns related to mortality in studies of Chinidin, particularly when used for long-term rhythm maintenance. Due to these findings, as well as the documented risk of serious proarrhythmia (worsening of heart rhythm), its use today may be reserved for specific or limited circumstances, based on the findings.

Q: Is there a risk of developing dependence or addiction with Chinidin use?

Official product information lists a caution regarding individuals with a history of drug abuse or dependence. This is noted because dependence may be more likely to develop in these individuals.

Q: Does Chinidin affect blood pressure?

Yes, regulatory documents note that Chinidin can cause hypotension, or low blood pressure. This effect is why individuals may experience dizziness or lightheadedness, particularly when changing position from sitting or lying down to standing.

Q: Why do official documents advise caution when combining Chinidin with certain antibiotics or antifungals?

Caution is officially advised when combining quinidine with antibiotics such as macrolides and aminoglycosides because they can worsen a condition called Myasthenia Gravis. Since Myasthenia Gravis is an absolute contraindication for Chinidin, caution must be exercised when co-administering medications that could worsen the condition.

Q: What is the difference in how Chinidin works at high heart rates versus low heart rates?

Official mechanism of action documents describe the drug’s action as 'use-dependent block.' This means that the drug's effect of blocking the heart's sodium channels is increased when the heart rate is faster and is decreased when the heart rate is slower.

Q: Why is it important to tell a dentist or surgeon that I am taking Chinidin?

Official patient information advises that you should inform any medical doctor or dentist in charge before undergoing any type of surgery, including dental procedures, or receiving emergency treatment. This is advised because the medication may interact with anesthetics and other products used during surgical or emergency procedures.

Q: Do doctors prescribe generic quinidine instead of branded combination drugs, and is it common?

Quinidine is available as a generic drug (for example, quinidine sulfate) and is also the active component in various branded combination products. The specific formulation chosen (generic, branded, or combination) is determined by the healthcare provider based on the condition being treated.

Q: What does it mean that Chinidin has 'proarrhythmic effects'?

Proarrhythmic effects refer to the documented potential for the drug to induce a new heart rhythm disorder or worsen an existing one. The most serious concern noted in regulatory warnings is the risk of Torsades de Pointes, a potentially life-threatening arrhythmia.

Q: Do common side effects like diarrhea or dizziness go away after a while?

Official patient information states that some common side effects, such as diarrhea, may subside after a period as the body adjusts to the medication. However, any persistent or concerning side effects warrant immediate review by a healthcare professional.

Q: What are the serious signs or symptoms that require immediate medical attention while taking Chinidin?

Signs that warrant immediate medical attention include a very fast or pounding heart rate, sudden severe dizziness, fainting, or difficulty breathing. The label also notes that unusual bleeding or bruising and the yellowing of the eyes or skin are serious symptoms that warrant urgent medical review.

Q: Can Chinidin cause unusual bleeding or bruising?

Yes, regulatory documents note that easy bruising or unusual bleeding are rare, serious side effects. These events can be associated with a severe drop in the platelet count, a blood condition known as thrombocytopenia.

Q: Can Chinidin be taken if a patient has a pacemaker?

The official label states that a complete heart block (AV block) is an absolute contraindication for use. However, this restriction does not apply if an implanted pacemaker is already present to regulate the heart rhythm.

Q: What is the difference between quinidine sulfate and quinidine gluconate?

The active component, quinidine, is prepared in different salt forms, such as sulfate and gluconate. Quinidine sulfate is typically used in immediate-release (short-acting) tablets, while quinidine gluconate is used in extended-release (slow-absorbing) tablets, which determines how quickly the medicine is released into the body.

Q: Does Chinidin have an anticholinergic effect, and what does that mean?

Yes, the drug is documented to have an anticholinergic effect, which means it interferes with specific nerve receptors, including those that are part of the Vagus nerve. This activity can result in a reduction of the heart's inhibitory control.

Q: Is it normal to feel dizzy or lightheaded when standing up quickly while on Chinidin?

Official information advises standing up slowly because this is typically related to the drug's effect on blood pressure. Dizziness or lightheadedness may occur, especially when getting up from a sitting or lying position.

How should Chinidin be stored and disposed of?

How to Store and Dispose of Quinidine

Quinidine sulfate tablets must be stored at controlled room temperature, specifically between 20 C to 25 C (68 F to 77 F). The product requires storage in a tight and light-resistant container, as the active substance can darken upon light exposure. The medicine must always be kept out of reach of children.

Disposal Instructions

Official disposal guidance states that unused or expired tablets should not be flushed down the toilet or poured down a drain, unless explicitly instructed by a healthcare provider or a local drug take-back program. If no take-back program is available, the product should be mixed with an unappealing substance, sealed in a container, and discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Chinidin found in:

A-Z Index: